[STUDY GUIDE] • HIGH-YIELD PRACTICE & REVIEW EDITION
NSG 552 Exam 3 Questions & Verified
Rationalized Answers, Updated 2026/2027
Edition, Wilkes University
Comprehensive Examination Question Bank • In-Depth Rationales • Concept Mapping
TOTAL QUESTIONS EXAM TOPICS RATIONALES
74 Questions 11 Modules 100% Verified
DOCUMENT OVERVIEW
This document contains 74 verified questions with detailed rationales covering psychopharmacology related to
anxiety disorders, eating disorders, and sleep disorders. Each item pairs a board-style question with the
correct answer and a concise explanation of the underlying principle, making it suitable for exam preparation,
course review, and rapid remediation.
EXAM BLUEPRINT & TOPIC DISTRIBUTION
Systematic breakdown of subject domains and exam coverage.
Topic Module Scope & Core Focus Questions Share (%)
Explores the pharmacological and therapeutic approaches to
Anxiety Disorders managing various anxiety disorders. 11 Qs 14.9%
Focuses on the characteristics and treatment options for
Binge Eating Disorder binge eating disorder. 7 Qs 9.5%
Examines the psychological and pharmacological aspects of
Somatic Symptom Disorders somatic symptom disorders and their management. 7 Qs 9.5%
Discusses the treatment options and pharmacological
Restless Legs Syndrome management for restless legs syndrome. 7 Qs 9.5%
Covers the role of different classes of antidepressants in
Antidepressants and Their Use treating mood disorders and eating disorders. 6 Qs 8.1%
Analyzes the use, risks, and pharmacokinetics of
Benzodiazepines benzodiazepines in treating anxiety and sleep disorders. 6 Qs 8.1%
Pharmacological Treatments for Details the various pharmacological treatments available for
Insomnia managing insomnia and their effects. 6 Qs 8.1%
Confidential • Student Study Edition • Practice & Review Guide Page 1 of 27
,STUDENT STUDY & MASTERY EDITION PRACTICE & REVIEW GUIDE
Examines the indications, side effects, and applications of
SSRIs and SNRIs SSRIs and SNRIs in treating various disorders. 6 Qs 8.1%
Trauma and Dissociative Explores the pharmacological treatment strategies for trauma
Disorders and dissociative disorders. 6 Qs 8.1%
Covers the general characteristics and pharmacological
Eating Disorders Overview treatment considerations for different eating disorders. 6 Qs 8.1%
Discusses the management and pharmacotherapy for various
Sleep/Wake Disorders sleep/wake disorders. 6 Qs 8.1%
Total Exam Coverage 11 Integrated Topic Modules 74 Qs 100.0%
Confidential • Student Study Edition • Practice & Review Guide Page 2 of 27
, STUDENT STUDY & MASTERY EDITION PRACTICE & REVIEW GUIDE
TOPIC 1: ANXIETY DISORDERS
11 Questions • 14.9% of Exam • Explores the pharmacological and therapeutic approaches to managing various anxiety disorders.
QUESTION 1
Acute anxiety
Correct Answer: First line for acute panic may be short term benzo use. short acting benzos cause rebound
anxiety and are the most abused.
Rationale: Short-acting benzodiazepines provide rapid relief for acute anxiety, but they can lead to rebound anxiety as their
effects wear off, creating a cycle of dependence. This is why they are often considered a short-term solution and are
frequently abused, making them less ideal for managing acute anxiety in the long run.
QUESTION 2
Benzodiazepines
Correct Answer: Withdrawal can be dangerous, even deadly. Stopping abruptly is not advised. Symptoms of
agitation, tension, irritability, and sz. may occur.
Rationale: This answer is correct because benzodiazepines are a class of sedative medications that can be habit-forming
and lead to physical dependence when used regularly. When individuals stop taking benzodiazepines abruptly, they can
experience severe withdrawal symptoms, such as those mentioned, due to the sudden loss of the medication's calming
effects on the brain and body.
QUESTION 3
Anxiety disorders
Correct Answer: Psychological disorders characterized by distressing, persistent anxiety or maladaptive
behaviors that reduce anxiety.
Rationale: This definition accurately captures the essence of anxiety disorders because it emphasizes the core features of
these conditions, namely the presence of distressing anxiety and maladaptive behaviors, which are essential components of
anxiety disorders as defined in psychiatric literature. This definition excludes conditions that may exhibit similar behaviors
but are not primarily driven by anxiety, thereby narrowing the scope to the specific group of disorders that are characterized
by anxiety as the primary symptom.
Confidential • Student Study Edition • Practice & Review Guide Page 3 of 27
NSG 552 Exam 3 Questions & Verified
Rationalized Answers, Updated 2026/2027
Edition, Wilkes University
Comprehensive Examination Question Bank • In-Depth Rationales • Concept Mapping
TOTAL QUESTIONS EXAM TOPICS RATIONALES
74 Questions 11 Modules 100% Verified
DOCUMENT OVERVIEW
This document contains 74 verified questions with detailed rationales covering psychopharmacology related to
anxiety disorders, eating disorders, and sleep disorders. Each item pairs a board-style question with the
correct answer and a concise explanation of the underlying principle, making it suitable for exam preparation,
course review, and rapid remediation.
EXAM BLUEPRINT & TOPIC DISTRIBUTION
Systematic breakdown of subject domains and exam coverage.
Topic Module Scope & Core Focus Questions Share (%)
Explores the pharmacological and therapeutic approaches to
Anxiety Disorders managing various anxiety disorders. 11 Qs 14.9%
Focuses on the characteristics and treatment options for
Binge Eating Disorder binge eating disorder. 7 Qs 9.5%
Examines the psychological and pharmacological aspects of
Somatic Symptom Disorders somatic symptom disorders and their management. 7 Qs 9.5%
Discusses the treatment options and pharmacological
Restless Legs Syndrome management for restless legs syndrome. 7 Qs 9.5%
Covers the role of different classes of antidepressants in
Antidepressants and Their Use treating mood disorders and eating disorders. 6 Qs 8.1%
Analyzes the use, risks, and pharmacokinetics of
Benzodiazepines benzodiazepines in treating anxiety and sleep disorders. 6 Qs 8.1%
Pharmacological Treatments for Details the various pharmacological treatments available for
Insomnia managing insomnia and their effects. 6 Qs 8.1%
Confidential • Student Study Edition • Practice & Review Guide Page 1 of 27
,STUDENT STUDY & MASTERY EDITION PRACTICE & REVIEW GUIDE
Examines the indications, side effects, and applications of
SSRIs and SNRIs SSRIs and SNRIs in treating various disorders. 6 Qs 8.1%
Trauma and Dissociative Explores the pharmacological treatment strategies for trauma
Disorders and dissociative disorders. 6 Qs 8.1%
Covers the general characteristics and pharmacological
Eating Disorders Overview treatment considerations for different eating disorders. 6 Qs 8.1%
Discusses the management and pharmacotherapy for various
Sleep/Wake Disorders sleep/wake disorders. 6 Qs 8.1%
Total Exam Coverage 11 Integrated Topic Modules 74 Qs 100.0%
Confidential • Student Study Edition • Practice & Review Guide Page 2 of 27
, STUDENT STUDY & MASTERY EDITION PRACTICE & REVIEW GUIDE
TOPIC 1: ANXIETY DISORDERS
11 Questions • 14.9% of Exam • Explores the pharmacological and therapeutic approaches to managing various anxiety disorders.
QUESTION 1
Acute anxiety
Correct Answer: First line for acute panic may be short term benzo use. short acting benzos cause rebound
anxiety and are the most abused.
Rationale: Short-acting benzodiazepines provide rapid relief for acute anxiety, but they can lead to rebound anxiety as their
effects wear off, creating a cycle of dependence. This is why they are often considered a short-term solution and are
frequently abused, making them less ideal for managing acute anxiety in the long run.
QUESTION 2
Benzodiazepines
Correct Answer: Withdrawal can be dangerous, even deadly. Stopping abruptly is not advised. Symptoms of
agitation, tension, irritability, and sz. may occur.
Rationale: This answer is correct because benzodiazepines are a class of sedative medications that can be habit-forming
and lead to physical dependence when used regularly. When individuals stop taking benzodiazepines abruptly, they can
experience severe withdrawal symptoms, such as those mentioned, due to the sudden loss of the medication's calming
effects on the brain and body.
QUESTION 3
Anxiety disorders
Correct Answer: Psychological disorders characterized by distressing, persistent anxiety or maladaptive
behaviors that reduce anxiety.
Rationale: This definition accurately captures the essence of anxiety disorders because it emphasizes the core features of
these conditions, namely the presence of distressing anxiety and maladaptive behaviors, which are essential components of
anxiety disorders as defined in psychiatric literature. This definition excludes conditions that may exhibit similar behaviors
but are not primarily driven by anxiety, thereby narrowing the scope to the specific group of disorders that are characterized
by anxiety as the primary symptom.
Confidential • Student Study Edition • Practice & Review Guide Page 3 of 27
